MorphoSys Net Receivables from 2010 to 2024
| MOR Stock | USD 18.42 0.01 0.05% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 42.7 M | Current Value 30.8 M | Quarterly Volatility 52.5 M |
Check MorphoSys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MorphoSys' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.4 M, Interest Expense of 115.4 M or Selling General Administrative of 90.5 M, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0 or PTB Ratio of 15.24. MorphoSys financial statements analysis is a perfect complement when working with MorphoSys Valuation or Volatility modules.
MorphoSys | Net Receivables |
Latest MorphoSys' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of MorphoSys AG ADR over the last few years. It is MorphoSys' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MorphoSys' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
MorphoSys Net Receivables Regression Statistics
| Arithmetic Mean | 81,358,713 | |
| Geometric Mean | 54,526,258 | |
| Coefficient Of Variation | 71.09 | |
| Mean Deviation | 48,536,353 | |
| Median | 85,790,044 | |
| Standard Deviation | 57,838,992 | |
| Sample Variance | 3345.3T | |
| Range | 168.8M | |
| R-Value | 0.12 | |
| Mean Square Error | 3552.7T | |
| R-Squared | 0.01 | |
| Significance | 0.68 | |
| Slope | 1,523,983 | |
| Total Sum of Squares | 46834.9T |
MorphoSys Net Receivables History
About MorphoSys Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include MorphoSys income statement, its balance sheet, and the statement of cash flows. MorphoSys investors use historical funamental indicators, such as MorphoSys's Net Receivables, to determine how well the company is positioned to perform in the future. Although MorphoSys investors may use each financial statement separately, they are all related. The changes in MorphoSys's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MorphoSys's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MorphoSys Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MorphoSys. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 42.7 M | 83.8 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for MorphoSys Stock Analysis
When running MorphoSys' price analysis, check to measure MorphoSys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MorphoSys is operating at the current time. Most of MorphoSys' value examination focuses on studying past and present price action to predict the probability of MorphoSys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MorphoSys' price. Additionally, you may evaluate how the addition of MorphoSys to your portfolios can decrease your overall portfolio volatility.